1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow 611 300 mg Q2W: new trials by email Literature Review of 611 300 mg Q2W trials Research Report on 611 300 mg Q2W
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of 611 in Chinese Adults With Moderate to Severe Chronic Obstructive Pulmonary Disease 611 300 mg Q2W, 611 450 mg Q2W, Matching placebo - Pulmonary Disease, Chronic Obstructive | Phase 2 | Completed | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 142 | 2023-12-08 | 2025-11-20 |
Pulmonary Disease, Chronic Obstructive (1)
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (1)
China (1)